First Tracks Biotherapeutics, Inc.
TRAXDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
1 upcoming, 1 past
How TRAX's past catalysts played out
No drugs found in this phase.
cancer
2 drugs in this indication
advanced GEP-NETs
1 drug in this indication
stem cell transplant preparation
1 drug in this indication
First-line unresectable hepatocellular carcinoma (HCC)
1 drug in this indication
First-line consolidation therapy in MRD-positive large B-cell lymphoma
1 drug in this indication
Alexander disease in pediatric and adult patients
1 drug in this indication
Alexander disease
1 drug in this indication
spinal cord injuries
1 drug in this indication
cholangiocarcinoma with acquired FGFR inhibitor resistance
1 drug in this indication
BCL (B-cell lymphoma)
1 drug in this indication
early-onset disc problems
1 drug in this indication
relapsed/refractory multiple myeloma
1 drug in this indication
weight loss
1 drug in this indication
senescent cell accumulation, aging-related metabolic dysfunction
1 drug in this indication
hematologic malignancy (follicular lymphoma)
1 drug in this indication
soft tissue sarcoma
1 drug in this indication
Pulmonary heart valve for pediatric patients with congenital pulmonary valve disease
1 drug in this indication
dermatomyositis in adults
1 drug in this indication
Recurrent atypical teratoid/rhabdoid tumor (CNS tumor)
1 drug in this indication
Recurrent urinary tract infections (UTIs)
1 drug in this indication
pancreatic cancer
1 drug in this indication
Mucopolysaccharidosis type IIIA (MPS IIIA, Sanfilippo syndrome type A) in pediatric patients
1 drug in this indication
Local anesthesia, nerve blocks, pain management
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
When is First Tracks Biotherapeutics, Inc.'s next FDA catalyst?→
First Tracks Biotherapeutics, Inc.'s (TRAX) next tracked catalyst is a Earnings expected November 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TRAX biotech catalysts?→
Add TRAX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow First Tracks Biotherapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.